Community Academic Profiles

Laura K. Bachrach

Publication Details

  • Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty.

    Badaru A, Wilson DM, Bachrach LK, Fechner P, Gandrud LM, Durham E, Wintergerst K, Chi C, Klein KO, Neely EK. J Clin Endocrinol Metab. 2006; 91 (5): 1862-7

    Dosing of monthly depot leuprolide (DL) in central precocious puberty (CPP) varies considerably. U.S. practitioners use 7.5-15 mg, in contrast with the international standard of 3.75 mg. Pubertal suppression using the newer 3-month DL also has been reported from Europe. To date there have been no direct comparisons of these different DL doses.

    PubMedID: 16449344

Stanford Medicine Resources:

Footer Links: